You are here:
| Reference : Role de l'inhibiteur des activateurs de plasminogene de type 1 dans l'angiogenese tumorale |
| Scientific journals : Article | |||
| Life sciences : Biochemistry, biophysics & molecular biology | |||
| http://hdl.handle.net/2268/63568 | |||
| Role de l'inhibiteur des activateurs de plasminogene de type 1 dans l'angiogenese tumorale | |
| French | |
| [en] Role of Plasminogen Activator Inhibitor Type 1 in Tumor Angiogenesis | |
Bajou, Khalid  [Université de Liège - ULg > Département des sciences de la vie > Biologie et génétique moléculaire >] | |
| Devy, L. [> > > >] | |
| Masson, Véronique [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >] | |
| Albert, V. [> > > >] | |
| Frankenne, Francis [ > > ] | |
| Noël, Agnès [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme >] | |
| Foidart, Jean-Michel [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >] | |
| 2001 | |
| Thérapie | |
| EDP Sciences | |
| 56 | |
| 5, Sep-Oct | |
| 465-72 | |
| Yes (verified by ORBi) | |
| International | |
| 0040-5957 | |
| Les Ulis | |
| France | |
| [en] The plasminogen/plasmin system plays a key role in cancer progression, presumably via mediating extracellular matrix degradation and tumour cell migration. High levels of components of the plasminogen activation system, and paradoxically also its inhibitor, plasminogen activator inhibitor 1 (PAI-1), have been correlated with a poor prognosis for patients with cancers of different types. Recent findings clearly suggest that PAI-1 is essential for capillary sprouting during tumour angiogenesis. Moreover, there is accumulating evidence that both the urokinase receptor and PAI-1 are multifunctional proteins involved not only in extracellular matrix proteolysis but also in cellular adhesion and migration through their binding site for vitronectin. The understanding of whether PAI-1 plays a regulatory role in angiogenesis by tightly controlling proteolytic activity or by influencing cell migration could allow a new anti-angiogenic approach for tumour therapy. | |
| http://hdl.handle.net/2268/63568 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
